Animal models of schizophrenia using different laboratory mouse strains

Acta Physiologica Sinica

Volumn 55, Issue 4, 2003, Pages 381-387

  Wu, Jin Hua ^a   Zou, Hong ^a   Yu, Jun ^a   Zhou, Xue Dong ^a   Xie, Qing Lian ^a   Jin, Mei Lei ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Animal model; Hyperlocomotion; MK801; Risperidone; Schizophrenia; Stereotypy

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RISPERIDONE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPOTHESIS; LOCOMOTION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; SCHIZOPHRENIA; STEREOTYPY; VIDEORECORDING;

ANIMALS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED ICR; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SPECIES SPECIFICITY;

EID: 0041322655     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Warner R, Girolamo D. Schizophrenia. Geneva: World Health Organization, 1995.
2. Diagnostic and Statistical and Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association, 1987.
3. Alan AB, Glen BB, Mathew TM. Animal Models in Psychiatry I, Clifton: Humana Press, 1991.
4. Amy RM, Raul RG, Marc GC, Beverly HK. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999;98:427-436.
5. Carlsson M, Carlsson A. Interactions between glutamateric and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990;13:272-276.
6. Carlsson A, Hansson LO, Waters N, Carlsson ML. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life Sci 1997;61:75-94.
7. Ban TA, Guy W, Wilson WH. Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification. Psychiatr Dev 1984;2(3):179-199.
8. Guan HG, Dai JZ, Xing Z. Atypical antipsychotic effects of Quetiapine fumarate in animal models. Acta Pharmacol Sin 2000;21:205-210.
9. Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 1970;11:303-404.
10. Griffith JD, Cavanaugh J, Held J, Oates JA. Dextroampetamine: evaluation of psychotomimetic properties in man. Arch Gen Psychiatry 1972;26:97-100.
11. Si TM, Su L. Study on animal behavior models induced by dizocilpine. Chin J Neurol 2000;33:158-160 (Chinese, English abstract).
12. Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH. The NMDA antagonist model for schizophrenia: promise and pitfall. Pharmacopsychiatry 1998;31(Suppl 2):104-109.
13. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-1308.